InsiderTrades

Anzalone Christopher Richard

SEC CIK 1423029 · EDGAR

Buying vs selling by month open-market trades, last 60 months, ARWR
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
ARWRARROWHEAD PHARMACEUTICALS, INC.CEO, Dir 3.80M — $57.40M 372021-10-202026-01-02

Most active insiders at ARWR, 12 months

#InsiderTitleBoughtSold
1 Anzalone Christopher RichardCEO, Dir —$24.01M
2 Hamilton James CChief Medical Off —$4.63M
3 O'Brien PatrickCOO —$3.12M
4 PERRY MICHAEL SDir —$2.00M
5 Ferrari MauroDir —$1.02M
6 Apel Daniel JosephCFO —$934.3K
7 OLUKOTUN ADEOYE YDir —$850.5K
8 Vakiener VictoriaDir —$679.5K
9 Waddill William D.Dir —$566.0K
10 Lu HongboDir —$228.3K

Transactions 37

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
M 2026-01-05 2026-01-02 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $66.10 -13.2K 3.80M -0.3% -$871.7K
DM 2025-12-30 2025-12-29 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale+OE $69.13 -51.7K 3.82M -1% -$3.58M
DM 2025-12-30 2025-12-29 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir M - OptEx $6.15 +51.7K 3.84M +1% +$318.1K
M 2025-12-23 2025-12-19+ ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $68.04 -26.0K 3.81M -0.7% -$1.77M
M 2025-12-19 2025-12-17 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $64.04 -85.0K 3.87M -2% -$5.44M
M 2025-12-16 2025-12-15+ ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $67.00 -184.3K 3.92M -4% -$12.35M
2025-12-16 2025-12-12 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir A - Grant $0.00 +180.0K 4.10M +5% $0
M 2025-04-11 2025-04-09+ ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $10.87 -141.1K 4.03M -3% -$1.53M
2025-03-17 2025-03-13 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $15.07 -51.4K 4.06M -1% -$775.0K
2025-03-17 2025-03-13 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir A - Grant $0.00 +340.0K 4.11M +9% $0
DM 2025-03-05 2025-03-03+ ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir M - OptEx $7.75 +300.0K 3.94M +8% +$2.33M
DM 2025-03-05 2025-03-03+ ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale+OE $17.58 -300.0K 3.77M -7% -$5.27M
2025-02-10 2025-02-07 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir A - Grant $20.10 +9,550 3.77M +0.3% +$192.0K
2025-01-06 2025-01-02 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $19.05 -11.5K 3.76M -0.3% -$219.5K
2024-12-23 2024-12-23 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $19.59 -12.6K 3.78M -0.3% -$246.1K
M 2024-12-20 2024-12-18 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $21.24 -26.7K 3.69M -0.7% -$567.5K
2024-12-20 2024-12-18 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir A - Grant $0.00 +100.0K 3.79M +3% $0
D 2024-02-02 2024-01-31 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir M - OptEx $14.54 +57.5K 3.77M +2% +$836.0K
DM 2024-02-02 2024-01-31 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale+OE $32.35 -57.5K 3.73M -2% -$1.86M
M 2024-01-04 2024-01-02 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $31.01 -9,952 3.72M -0.3% -$308.6K
2023-12-22 2023-12-20 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $28.54 -12.0K 3.73M -0.3% -$342.5K
2023-10-27 2023-10-25 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $24.21 -24.3K 3.74M -0.6% -$589.2K
DM 2023-09-20 2023-09-18 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale+OE $28.12 -57.8K 3.76M -2% -$1.62M
D 2023-09-20 2023-09-18 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir M - OptEx $4.75 +57.8K 3.82M +2% +$274.3K
DM 2023-05-05 2023-05-03+ ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale+OE $39.32 -104.9K 3.76M -3% -$4.13M
DM 2023-05-05 2023-05-03+ ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir M - OptEx $2.01 +104.9K 3.81M +3% +$210.9K
M 2022-12-20 2022-12-16+ ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir A - Grant $0.00 +252.4K 3.72M +7% $0
M 2022-09-29 2022-09-27 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir M - OptEx $30.79 -40.6K 3.47M -1% -$1.25M
2022-07-12 2022-07-08 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir D - Sale to Iss $0.00 -551.2K 3.51M -14% $0
D 2022-07-11 2022-07-07 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir M - OptEx $14.54 +2,501 4.06M +0.1% +$36.4K
DM 2022-02-14 2022-02-11 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale+OE $51.91 -146.4K 4.16M -3% -$7.60M
D 2022-02-14 2022-02-11 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir M - OptEx $5.19 +146.4K 4.20M +4% +$759.8K
D 2022-01-07 2022-01-07 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir M - OptEx $5.19 +11.8K 4.06M +0.3% +$61.3K
2022-01-04 2022-01-01 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir A - Grant $0.00 +800.0K 4.05M +25% $0
D 2021-12-23 2021-12-23 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir M - OptEx $5.19 +11.8K 3.25M +0.4% +$61.3K
M 2021-12-17 2021-12-15 ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $67.56 -60.0K 3.25M -2% -$4.05M
M 2021-10-22 2021-10-20+ ARWR ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard CEO, Dir S - Sale $65.77 -65.0K 3.28M -2% -$4.27M

Purchase Sale Sale after option exercise All abbreviations